Microsoft Looks Beyond OpenAI, Student Cracks Century-Old Math Problem, and Research Shows How Aspirin Fights Cancer

Microsoft is shifting its AI strategy to reduce reliance on OpenAI by developing its own models, particularly the MAI family, which have shown competitive performance against leading models from OpenAI and Anthropic. The company is exploring collaborations with other AI firms like XAI, Meta, and DeepSeek to enhance its capabilities and independence.

In a significant academic achievement, Divya Tyagi, a graduate student at Penn State University, has refined a century-old mathematical problem related to wind turbine aerodynamics. Her research revises Herman Glauert's 1920s rotor disc solution using calculus of variations, providing clearer analytical solutions for thrust and bending moment coefficients. Tyagi's findings suggest that even minor movements of turbine blades can generate substantial forces, indicating that a 1% increase in power coefficient for large turbines could lead to significant energy output improvements.

Research from the University of Cambridge has uncovered aspirin's potential in cancer treatment by enhancing the immune system's ability to target metastatic cells. The study shows that aspirin reduces thromboxane A2 production, which typically suppresses T cell function against cancer. In mouse models, aspirin-treated subjects exhibited fewer metastases, indicating a promising avenue for cancer therapies. The AdAspirin Clinical Trial aims to assess aspirin's effectiveness in preventing early-stage cancer recurrence, building on evidence that daily aspirin use correlates with lower cancer mortality rates. While aspirin presents potential benefits, researchers caution about its serious side effects and emphasize the need for medical consultation before use. This research could lead to affordable cancer treatment alternatives, particularly targeting the thromboxane A2 pathway, which is crucial given that metastasis accounts for about 90% of cancer-related deaths globally.